• 01/18/2025

SVB crash and the future of venture lending in Israel – analysis

Jerusalem Post It remains to be seen how existing SVB loan facilities will be treated and to whom they will be assigned, but the real question is who, if anyone, will fill the large void left by SVB? https://www.jpost.com/business-and-innovation/opinion/article-735125

Read More

Phishing cyberattacks are on the rise, but Acronis helps stop them – opinion

Jerusalem Post Candid Wuest: Phishing now accounts for approximately 76% of all cyberattacks, and it’s increasingly difficult for everyday people to know what messages they receive are legitimate. https://www.jpost.com/business-and-innovation/opinion/article-734920

Read More

Dealing with finances is a marathon, not a sprint – opinion

Jerusalem Post World champion runner Haile Gebrselassie said: “When you run the marathon, you run against the distance, not against the other runners and not against the time.” https://www.jpost.com/business-and-innovation/opinion/article-734582

Read More

SVB collapse shows Israeli hi-tech should stay in Israel – opinion

Jerusalem Post The lesson from this should be that despite domestic turmoil or geopolitical threats faced, Israeli entrepreneurs are safer with their money at home https://www.jpost.com/business-and-innovation/opinion/article-734109

Read More

Financial uncertainty doesn’t bode well for global business – opinion

Jerusalem Post Until now, most tax treaties are bilateral and not multilateral. MoMA doesn’t actually prescribe anything new, but it presents current “best” practice for resolving multilateral tax disputes https://www.jpost.com/business-and-innovation/opinion/article-733888

Read More

Israeli stock market will recover like Israelites after the golden calf – opinion

Jerusalem Post Remember the famous investing principle of buying low and selling high. Investors who panic often end up selling low. https://www.jpost.com/business-and-innovation/opinion/article-733894

Read More

Israeli-Canadian firm sprays COVID, the flu away – opinion

Jerusalem Post You can buy enovid in Israel, Europe and parts of Southeast Asia, but not yet in North America, where NO is approved only as a prescription drug to help with blue baby syndrome, https://www.jpost.com/business-and-innovation/opinion/article-733870

Read More

AI and its implications for copyright -opinion

Jerusalem Post It is clear that for the machine to write or draw anything, it needs access to existing information, documents, research, drawings, pictures, etc. https://www.jpost.com/business-and-innovation/tech-and-start-ups/article-733356

Read More

What are the top Israel tech trends for 2023? – opinion

Jerusalem Post OurCrowd’s Global Investor Summit in Jerusalem always predicts the top tech trends for the next year. What should we look forward to in 2023? https://www.jpost.com/business-and-innovation/opinion/article-732503

Read More

Israeli capital markets aren’t used to genuine success stories – opinion

Jerusalem Post The sleepy local markets can’t fathom cyber security company HUB Security’s success, but outside of Israel, things are decidedly different. https://www.jpost.com/business-and-innovation/opinion/article-731110

Read More